Jean-paul Kress - Net Worth and Insider Trading
Jean-paul Kress Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jean-paul Kress owns 2 companies in total, including Sarepta Therapeutics Inc (SRPT) , and Biogen Inc (BIIB) .
Click here to see the complete history of Jean-paul Kress’s form 4 insider trades.
Insider Ownership Summary of Jean-paul Kress
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SRPT | Sarepta Therapeutics Inc | 2015-09-29 | director |
| BIIB | Biogen Inc | 2017-06-14 | EVP Pres Int'l & Global Hd GTO |
Jean-paul Kress Trading Performance
Jean-paul Kress Ownership Network
Ownership Network List of Jean-paul Kress
Ownership Network Relation of Jean-paul Kress
Jean-paul Kress Owned Company Details
What does Sarepta Therapeutics Inc do?
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.
Who are the key executives at Sarepta Therapeutics Inc?
Jean-paul Kress is the director of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Tech Ops Officer Bilal Arif , SVP & General Counsel Ryan Edward Brown , and Chief Financial Officer Ian Michael Estepan .
Sarepta Therapeutics Inc (SRPT) Insider Trades Summary
Over the past 18 months, Jean-paul Kress made no insider transaction in Sarepta Therapeutics Inc (SRPT). Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 103,270 shares made by Michael Andrew Chambers , a net purchase of 25,026 shares made by Douglas S Ingram , and a net purchase of 3,780 shares made by Louise Rodino-klapac .
In summary, during the past 3 months, insiders sold 0 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 858 shares of Sarepta Therapeutics Inc (SRPT) were sold and 132,076 shares were bought by its insiders, resulting in a net purchase of 131,218 shares.
Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sarepta Therapeutics Inc Insider Transactions
Jean-paul Kress Mailing Address
Above is the net worth, insider trading, and ownership report for Jean-paul Kress. You might contact Jean-paul Kress via mailing address: 215 First Street, Suite 415, Cambridge Ma 02142.
